1. Benzo parathion compound represented by formula (1),their individual enantiomers, diastereoisomers, individual tautomers, or a pharmaceutically acceptable salt thereof, wherein: X is N or CR； R is hydrogen, halogen, CN, substituted or unsubstituted C₁₋₆ alkyl, substituted or unsubstituted C₃₋₈ cycloalkyl, OR⁹,Nr.83040； R1 or COR1；R¹ is hydrogen, halogen, CN, substituted or unsubstituted C₁₋₆ alkyl, substituted or unsubstituted C₃₋₈ cycloalkyl, OR⁹,Nr.83040； R1 or COR1；R² is hydrogen, halogen, CN, substituted or unsubstituted C₁₋₆ alkyl, substituted or unsubstituted C₃₋₈ cycloalkyl, OR⁹,Nr.83040； R1 or COR1；R³ is hydrogen, halogen, CN, substituted or unsubstituted C₁₋₆ alkyl, substituted or unsubstituted C₃₋₈ cycloalkyl, OR⁹,Nr.83040； R1 or COR1；R⁴ is hydrogen, halogen, CN, substituted or unsubstituted C₁₋₆ alkyl, substituted or unsubstituted C₃₋₈ cycloalkyl, OR⁹,Nr.83040； R1 or COR1；R⁵ is hydrogen, halogen, CN, substituted or unsubstituted C₁₋₆ alkyl, substituted or unsubstituted C₃₋₈ cycloalkyl, OR⁹,Nr.83040； R1 or COR1；R⁶ is hydrogen, halogen, CN, substituted or unsubstituted C₁₋₆ alkyl, substituted or unsubstituted C₃₋₈ cycloalkyl, OR⁹,NR¹⁰OR¹¹ or COR¹²；R⁷ is hydrogen, halogen, CN, substituted or unsubstituted C₁₋₆ alkyl, substituted or unsubstituted C₃₋₈ cycloalkyl, OR⁹,NR¹⁰OR¹¹ or COR¹²；R⁸ is substituted or unsubstituted C₁₋₆ alkyl, substituted or unsubstituted C₃₋₈ cycloalkyl, substituted or unsubstituted aryl or substituted or unsubstituted heteroaryl； n is 0, 1 or 2； R⁹ is hydrogen or substituted or unsubstituted C₁₋₆ alkyl； R¹⁰ is hydrogen or substituted or unsubstituted C₁₋₆ alkyl； R¹¹ is hydrogen, substituted or unsubstituted C₁₋₆ alkyl, substituted or unsubstituted heterocycle or substituted or unsubstituted C₆₋₁₀ aryl； R¹² is hydrogen, hydroxyl, substituted or unsubstituted heterocycle, substituted or unsubstituted C₆₋₁₀ aryl or substituted or unsubstituted C₁₋₆ alkyl；In addition to formula compounds (2) and (3). A pharmaceutical ingredient containin
